WO2010091649A4 - Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac - Google Patents

Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac Download PDF

Info

Publication number
WO2010091649A4
WO2010091649A4 PCT/CZ2010/000011 CZ2010000011W WO2010091649A4 WO 2010091649 A4 WO2010091649 A4 WO 2010091649A4 CZ 2010000011 W CZ2010000011 W CZ 2010000011W WO 2010091649 A4 WO2010091649 A4 WO 2010091649A4
Authority
WO
WIPO (PCT)
Prior art keywords
weight
nicotine
substances
concentration
group
Prior art date
Application number
PCT/CZ2010/000011
Other languages
English (en)
Other versions
WO2010091649A3 (fr
WO2010091649A2 (fr
Inventor
Dobromil KOŠÍK
Milan Dittrich
Original Assignee
Heglund, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CZ20090080A external-priority patent/CZ200980A3/cs
Priority to JP2011548524A priority Critical patent/JP2012517402A/ja
Priority to US13/147,597 priority patent/US20110293535A1/en
Priority to CA2751271A priority patent/CA2751271A1/fr
Priority to ES10721627.7T priority patent/ES2606546T3/es
Priority to EP10721627.7A priority patent/EP2395974B1/fr
Priority to EA201100896A priority patent/EA201100896A1/ru
Priority to SG2011039500A priority patent/SG171870A1/en
Application filed by Heglund, A.S. filed Critical Heglund, A.S.
Priority to CN2010800073110A priority patent/CN102316850A/zh
Priority to AU2010213244A priority patent/AU2010213244A1/en
Publication of WO2010091649A2 publication Critical patent/WO2010091649A2/fr
Publication of WO2010091649A3 publication Critical patent/WO2010091649A3/fr
Publication of WO2010091649A4 publication Critical patent/WO2010091649A4/fr
Priority to ZA2011/03096A priority patent/ZA201103096B/en
Priority to IL212720A priority patent/IL212720A/en
Priority to US16/563,824 priority patent/US20200022905A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet une composition destinée à une absorption buccale de nicotine dans la circulation systémique et à une distribution au système nerveux central dans le but d'une désaccoutumance au tabac ou d'une substitution nicotinique dans des conditions hostiles au tabac. La composition contient une solution de nicotine se présentant sous la forme d'une base et/ou de son sel avec un acide organique dans une concentration de 0,01 à 8,00 % en poids et des substances ayant un effet mucolytique. Une dose d'application unique contient de 0,05 à 3,00 mg de nicotine.
PCT/CZ2010/000011 2009-02-11 2010-02-03 Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac WO2010091649A2 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
AU2010213244A AU2010213244A1 (en) 2009-02-11 2010-02-03 A composition for buccal absorption of nicotine for the purpose of smoking cessation
SG2011039500A SG171870A1 (en) 2009-02-11 2010-02-03 A composition for buccal absorption of nicotine for the purpose of smoking cessation
CA2751271A CA2751271A1 (fr) 2009-02-11 2010-02-03 Composition pour absorption buccale de nicotine dans le but d'une desaccoutumance au tabac
ES10721627.7T ES2606546T3 (es) 2009-02-11 2010-02-03 Compuesto destinado a la absorción bucal de nicotina con el objetivo de dejar de fumar
CN2010800073110A CN102316850A (zh) 2009-02-11 2010-02-03 一种用于戒烟的口腔吸收尼古丁组合物
EA201100896A EA201100896A1 (ru) 2009-02-11 2010-02-03 Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение
US13/147,597 US20110293535A1 (en) 2009-02-11 2010-02-03 Composition for buccal absorption of nicotine for the purpose of smoking cessation
JP2011548524A JP2012517402A (ja) 2009-02-11 2010-02-03 禁煙を目的としたニコチンを頬側吸収するための組成物
EP10721627.7A EP2395974B1 (fr) 2009-02-11 2010-02-03 Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac
ZA2011/03096A ZA201103096B (en) 2009-02-11 2011-04-28 A composition for buccal absorption of nicotine for the purpose of smoking cessation
IL212720A IL212720A (en) 2009-02-11 2011-05-05 Nicotine preparation for the absorption of the cheek for smoking cessation
US16/563,824 US20200022905A1 (en) 2009-02-11 2019-09-07 Composition for buccal absorption of nicotine for the purpose of smoking cessation and method for administering

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CZ20090080A CZ200980A3 (cs) 2009-02-11 2009-02-11 Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
CZPV2009-80 2009-02-11
CZ2009829 2009-12-09
CZPV2009-829 2009-12-09

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/147,597 A-371-Of-International US20110293535A1 (en) 2009-02-11 2010-02-03 Composition for buccal absorption of nicotine for the purpose of smoking cessation
US16/563,824 Continuation US20200022905A1 (en) 2009-02-11 2019-09-07 Composition for buccal absorption of nicotine for the purpose of smoking cessation and method for administering

Publications (3)

Publication Number Publication Date
WO2010091649A2 WO2010091649A2 (fr) 2010-08-19
WO2010091649A3 WO2010091649A3 (fr) 2010-11-11
WO2010091649A4 true WO2010091649A4 (fr) 2010-12-29

Family

ID=69162740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2010/000011 WO2010091649A2 (fr) 2009-02-11 2010-02-03 Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac

Country Status (14)

Country Link
US (2) US20110293535A1 (fr)
EP (1) EP2395974B1 (fr)
JP (1) JP2012517402A (fr)
KR (1) KR20110114552A (fr)
CN (1) CN102316850A (fr)
AU (1) AU2010213244A1 (fr)
CA (1) CA2751271A1 (fr)
EA (1) EA201100896A1 (fr)
ES (1) ES2606546T3 (fr)
IL (1) IL212720A (fr)
PT (1) PT2395974T (fr)
SG (1) SG171870A1 (fr)
WO (1) WO2010091649A2 (fr)
ZA (1) ZA201103096B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US20140166028A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit
US20140166027A1 (en) * 2012-12-14 2014-06-19 Richard C. Fuisz Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
MX2015015175A (es) 2013-05-06 2016-01-12 Pax Labs Inc Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos.
US9597298B2 (en) * 2013-06-07 2017-03-21 Remi Shrivastava Composition for topical application comprising glycerol and tannins
EP3076805A4 (fr) 2013-12-05 2017-10-11 PAX Labs, Inc. Formulations liquides de nicotine pour dispositifs générateurs d'aérosol et procédés correspondants
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
HUE053216T2 (hu) 2013-12-23 2021-06-28 Juul Labs Int Inc Párologtató eszközös rendszerek
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
UA124185C2 (uk) 2014-12-05 2021-08-04 Джуул Лебз, Інк. Пристрій для точного контролю дози
CN104770864B (zh) * 2015-02-13 2016-08-24 华健 一种清热润喉的电子雾化液及其制备方法
WO2016133890A1 (fr) * 2015-02-19 2016-08-25 Srq Patent Holdings, Llc Compositions pour cigarettes électroniques
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
CA2914089C (fr) 2015-12-03 2018-12-18 Euro-Pharm International Canada Inc. Formulations de liquide renfermant de la nicotine et utilisations associees
MX2018009703A (es) 2016-02-11 2019-07-08 Juul Labs Inc Cartuchos de fijacion segura para dispositivos vaporizadores.
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
US20240016198A1 (en) * 2019-01-25 2024-01-18 China Tobacco Hunan Industrial Co., Ltd. Water-based electronic cigarette liquid
CN111000283A (zh) * 2019-12-13 2020-04-14 武汉红金叶新材料科技有限公司 一种用于气溶胶装置的电子烟油及其制备方法和应用
SE546142C2 (en) * 2020-04-03 2024-06-11 Liw Innovation Ab New compositions for oral use
MX2023012528A (es) * 2021-04-23 2023-10-31 Thomas Meneghini Desinfectante y uso del mismo.
CN116649576A (zh) * 2023-06-14 2023-08-29 深圳市吉迩科技有限公司 一种含有抑菌抗氧化组合物的尼古丁口含制品及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196524A (ja) * 1987-02-10 1988-08-15 Wakunaga Pharmaceut Co Ltd 経粘膜吸収型制ガン作用調節剤
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
WO1997038662A2 (fr) * 1996-04-12 1997-10-23 Flemington Pharmaceutical Corporation Pulverisateur ou capsule polaire d'aerosols buccaux
US20080138399A1 (en) * 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
AU2005247369A1 (en) * 2004-05-10 2005-12-08 Mdrna, Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
JP5296557B2 (ja) * 2006-02-13 2013-09-25 オリエント ファーマ(サモア)カンパニー,リミティド 流涎症の治療のためのアルファ−2受容体アゴニスト(クロニジン)と抗ムスカリン剤(オキシブチニン)との組み合わせ
WO2008069972A2 (fr) * 2006-12-01 2008-06-12 Aradigm Corporation Systèmes destinés à mettre fin à l'usage du tabac
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition

Also Published As

Publication number Publication date
KR20110114552A (ko) 2011-10-19
ZA201103096B (en) 2011-12-28
JP2012517402A (ja) 2012-08-02
SG171870A1 (en) 2011-07-28
EP2395974B1 (fr) 2016-09-07
WO2010091649A3 (fr) 2010-11-11
IL212720A (en) 2016-02-29
CA2751271A1 (fr) 2010-08-19
EP2395974A2 (fr) 2011-12-21
AU2010213244A1 (en) 2010-08-19
WO2010091649A2 (fr) 2010-08-19
IL212720A0 (en) 2011-07-31
US20200022905A1 (en) 2020-01-23
ES2606546T3 (es) 2017-03-24
US20110293535A1 (en) 2011-12-01
EA201100896A1 (ru) 2012-01-30
PT2395974T (pt) 2016-12-14
CN102316850A (zh) 2012-01-11

Similar Documents

Publication Publication Date Title
WO2010091649A4 (fr) Composition pour absorption buccale de nicotine dans le but d'une désaccoutumance au tabac
JP6405310B2 (ja) ヒドロキシチロソール及びその誘導体の体内吸収促進剤及びその利用
KR20070119545A (ko) 입냄새 치료를 위한 항미생물 활성을 갖는 화합물
ITRM980425A1 (it) Composizione ad attivita' neuroprotettiva per la prevenzione ed il trattamento delle alterazioni nervose e comportamentali legate a stati
JP6316825B2 (ja) チューインガム
JP2014208715A (ja) 着香粘土ベースの治療用組成物
Cao et al. Inhibition of pathogenic microbes in oral infectious diseases by natural products: Sources, mechanisms, and challenges
Deshpande et al. Phytosomes: A noval drug delivery system for phytoconstituents
US20230033276A1 (en) Active ingredient-containing nanoemulsions
CN111511362A (zh) 口腔组合物及使用方法
JP5752958B2 (ja) 口腔用組成物
WO2009151299A3 (fr) Dérivés de styrylbenzofurane comme inhibiteurs de la formation de fibrilles d’amyloïde bêta et leur procédé de préparation
Aidaros Natural Enamel Remineralizing Agents
Ameen Natural Dentin Remineralizing Agents
Elkhateeb et al. Nanostructured Lipid Carrier Technology to Enhance Natural Extracts Delivery: Potential of Skin Regeneration.
RO136022A0 (ro) Compoziţie fitoterapeutică pe bază de extract gemoterapic de corylus avellana îmbogăţit cu nanocomplexe de crisină/ciclodextrine destinat fibrozei hepatice în diabetul zaharat şi metodă de obţinere aacesteia
TWI484958B (zh) 用於戒菸之口腔吸收尼古丁組成物
WO2023248187A1 (fr) Composition orale comprenant un modulateur de récepteur
JP5659265B2 (ja) 炎症性歯槽骨吸収抑制剤
ITMI20002665A1 (it) Prodotti alimentari fitoterapici
CZ21661U1 (cs) Bukální aerodisperze s nikotinem
TW201615176A (zh) 液體活化系統
TH80762B (th) สารผสมที่ใช้ทางปากซึ่งประกอบด้วยสารสกัดของพืชสกุลรอสมารินัส (Rosmarinus) และวิธีการที่สัมพันธ์กัน
ITMI20111259A1 (it) Composizione orosolubile a rapida disgregazione contenente derivati di curcumina
TH80762A (th) องค์ประกอบที่ใช้ทางปากซึ่งประกอบด้วยสารสกัดของพืชสกุลรอสมารินัส และวิธีการที่สัมพันธ์กัน

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080007311.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10721627

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 840/MUMNP/2011

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 212720

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2010213244

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2011001217

Country of ref document: CL

ENP Entry into the national phase

Ref document number: 2010213244

Country of ref document: AU

Date of ref document: 20100203

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011548524

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 20117015113

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 201100896

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2751271

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2010721627

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010721627

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2011/008123

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 13147597

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE